# Oscar Health (OSCR) — Earnings

OSCR · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/oscr/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $1.10 |
| EPS estimate | $0.40 |
| EPS surprise | +173.22% |
| Revenue surprise | +1.25% |
| Revenue | $4.8B |
| Revenue estimate | $4.7B |
| Reported | Aug 6, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1568651/000156865126000069/oscr-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/41e70cf8-c56d-f61b-9d20-748006236bc7.html) |

Oscar Health reported Q2 2026 results on August 6, 2026. Earnings per share were $1.10, 173.22% above the $0.40 estimate. Revenue reached $4.8 billion, 1.25% above the $4.7 billion consensus and the highest in the table. In Q2 2025, Oscar posted a loss of $0.89 per share on $2.9 billion of revenue, so the latest quarter marks a swing to profit and revenue growth of about 66%.

Of the 20 quarters shown, 15 were losses, and each full year from 2022 to 2025 ended with a loss per share: $2.85, $1.20, $0.02 and $1.74. All five profitable quarters fell in the first half of a year: Q1 and Q2 2024, Q1 2025, and Q1 and Q2 2026. The first half of 2026 adds up to $3.17, the strongest half year in the table. Oscar beat the EPS estimate in 11 of the 20 quarters.

Oscar reported third-quarter results between November 6 and November 10 in each of the past five years. That points to early November 2026 for the Q3 2026 report. The third quarter was a loss in each year of the table, so the next report will show whether this year's profits extend past mid-year.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 6, 2026 | $0.40 | $1.10 | 173.22% | $4.7B | $4.8B |
| Q1 2026 | May 6, 2026 | $1.11 | $2.07 | 86.81% | $4.9B | $4.6B |
| Q4 2025 | Feb 10, 2026 | −$0.89 | −$1.24 | -38.59% | $3.1B | $2.7B |
| Q3 2025 | Nov 6, 2025 | −$0.54 | −$0.53 | 2.56% | $3.1B | $2.9B |
| Q2 2025 | Aug 6, 2025 | −$0.81 | −$0.89 | -9.99% | $2.9B | $2.9B |
| Q1 2025 | May 7, 2025 | $0.79 | $0.92 | 16.06% | $2.8B | $3.0B |
| Q4 2024 | Feb 4, 2025 | −$0.59 | −$0.62 | -5.07% | $2.5B | $2.3B |
| Q3 2024 | Nov 7, 2024 | −$0.17 | −$0.22 | -28.35% | $2.3B | $2.4B |
| Q2 2024 | Aug 7, 2024 | $0.16 | $0.20 | 23.69% | $2.1B | $2.2B |
| Q1 2024 | May 7, 2024 | $0.27 | $0.62 | 127.94% | $2.0B | $2.1B |
| Q4 2023 | Feb 7, 2024 | −$0.72 | −$0.66 | 8.65% | $1.4B | $1.4B |
| Q3 2023 | Nov 7, 2023 | −$0.47 | −$0.29 | 38.62% | $1.4B | $1.4B |
| Q2 2023 | Aug 8, 2023 | −$0.22 | −$0.07 | 68.40% | $1.4B | $1.5B |
| Q1 2023 | May 9, 2023 | −$0.06 | −$0.18 | -197.52% | $1.3B | $1.4B |
| Q4 2022 | Feb 9, 2023 | −$1.14 | −$1.05 | 7.51% | $1.2B | $967.5M |
| Q3 2022 | Nov 8, 2022 | −$0.72 | −$0.91 | -26.56% | $1.1B | $1.3B |
| Q2 2022 | Aug 11, 2022 | −$0.48 | −$0.53 | -10.72% | $1.1B | $1.4B |
| Q1 2022 | May 10, 2022 | −$0.21 | −$0.36 | -68.54% | $1.0B | $972.8M |
| Q4 2021 | Feb 10, 2022 | −$0.98 | −$0.95 | 2.91% | $564.5M | $496.1M |
| Q3 2021 | Nov 10, 2021 | −$0.73 | −$1.02 | -40.42% | $543.7M | $673.5M |

## Frequently Asked Questions

### When did Oscar Health (OSCR) last report earnings?

Oscar Health last reported on Aug 6, 2026, covering fiscal Q2 2026.

### Did OSCR beat earnings estimates?

Yes. Oscar Health reported EPS of $1.10 for Q2 2026 against a $0.40 estimate — a 173.22% beat.

### How much revenue did OSCR report last quarter?

Oscar Health reported $4.8B in revenue for Q2 2026, against a consensus estimate of $4.7B.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).